AlphaCrest Capital Management’s National Instruments Corp NATI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-50,620
Closed -$1.58M 1420
2022
Q2
$1.58M Buy
50,620
+8,664
+21% +$307K 0.08% 450
2022
Q1
$1.7M Sell
41,956
-24,185
-37% -$976K 0.1% 302
2021
Q4
$2.89M Buy
66,141
+11,664
+21% +$496K 0.11% 244
2021
Q3
$2.14M Buy
54,477
+37,856
+228% +$1.58M 0.11% 278
2021
Q2
$703K Buy
16,621
+4,786
+40% +$202K 0.03% 820
2021
Q1
$511K Buy
11,835
+4,412
+59% +$194K 0.03% 783
2020
Q4
$326K Sell
7,423
-43
-0.6% -$1.6K 0.03% 887
2020
Q3
$267K Sell
7,466
-16,467
-69% -$598K 0.03% 920
2020
Q2
$926K Buy
+23,933
New +$905K 0.15% 163
2020
Q1
Sell
-23,070
Closed -$977K 1332
2019
Q4
$977K Sell
23,070
-41,081
-64% -$1.72M 0.08% 359
2019
Q3
$2.69M Buy
64,151
+6,982
+12% +$300K 0.16% 145
2019
Q2
$2.4M Buy
57,169
+38,655
+209% +$1.65M 0.21% 110
2019
Q1
$821K Buy
+18,514
New +$839K 0.12% 262

Other funds holding NATI

AlphaCrest Capital Management's NATI Position: Q3 2022 in Review

AlphaCrest Capital Management sold out of National Instruments Corp (NATI) in Q3 2022, closing a stake of 50,620 shares — an estimated $1.58M sold.

AlphaCrest Capital Management first reported a position in NATI in Q1 2019 and held it in 13 quarters. The position peaked at $2.89M in Q4 2021. 294 funds tracked by Wall St. Rank hold NATI as of Q3 2022.

  • AlphaCrest Capital Management reported no remaining National Instruments Corp position as of Q3 2022 after selling out during the quarter.
  • AlphaCrest Capital Management sold 50,620 National Instruments Corp shares in Q3 2022, an estimated $1.58M.
  • AlphaCrest Capital Management first reported a position in National Instruments Corp in Q1 2019 and held it in 13 quarters.
  • AlphaCrest Capital Management's National Instruments Corp position peaked at $2.89M in Q4 2021.
  • 294 funds tracked by Wall St. Rank held National Instruments Corp as of Q3 2022.

Based on AlphaCrest Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.